Exact Sciences share price today

(EXAS)

Exact Sciences share price is $57.48 & ₹4,916.72 as on 27 Dec 2024, 2.30 'hrs' IST

$57.48

▲

-0.63

(-1.08%)

Market is closed - opens 8 PM, 27 Dec 2024

View live Exact Sciences share price in Dollar and Rupees. Guide to invest in Exact Sciences from India. Also see the sentimental analysis on Indian investors investing in Exact Sciences. Get details on the Indian mutual funds that are investing in Exact Sciences. Get Analyst recommendations and forecasts along with all the Exact Sciences's financials.

Exact Sciences share price movements

Today's Low: $57.29
Today's High: $58.55
$57.48
0.33%
Downside
Day's Volatility :2.15%
Upside
1.83%
52 Weeks Low: $40.62
52 Weeks High: $79.62
$57.48
29.32%
Downside
52 Weeks Volatility :48.98%
Upside
27.81%

Exact Sciences Returns

Period	Exact Sciences Corporation	Sector (Health Care)	Index (Russel 2000)
3 Months	-12.86%	-8.8%	0.0%
6 Months	36.05%	-4.3%	0.0%
1 Year	-24.09%	2.7%	0.0%
3 Years	-21.75%	-0.8%	-21.8%

Exact Sciences Key Statistics

in dollars & INR

Previous Close	$58.11
Open	$57.86
Today's High	$58.55
Today's Low	$57.29
Market Capitalization	$10.6B
Today's Volume	$950.7K
52 Week High	$79.62
52 Week Low	$40.624
Revenue TTM	$2.7B
EBITDA	$-11.3M
Earnings Per Share (EPS)	$-1.16
Profit Margin	-7.95%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-6.76%

How to invest in Exact Sciences from India?

It is very easy for Indian residents to invest directly in Exact Sciences from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Exact Sciences stock in both Indian Rupees (INR) and US Dollars (USD). Search for Exact Sciences or EXAS on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Exact Sciences or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Exact Sciences shares which would translate to 0.015 fractional shares of Exact Sciences as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Exact Sciences, in just a few clicks!

Returns in Exact Sciences for Indian investors in Rupees

Investment Value

₹1,00,000

Exact Sciences investment value today

Current value as on today

₹78,751

Returns

₹21,249

(-21.25%)

Returns from Exact Sciences Stock

₹24,089 (-24.09%)

Dollar Returns

₹2,840 (+2.84%)

Indian investors sentiment towards Exact Sciences

-65.75%

Period: Sep 27, 2024 to Dec 26, 2024. Change in 30 Days versus previous period

Investment in Exact Sciences from India has reduced in the last 30 days as on Dec 27, 2024. -65.75% less purchase transactions for Exact Sciences in the last 30 days versus the previous period.

-8%

Period: Sep 27, 2024 to Dec 26, 2024. Change in 30 Days versus previous period

Search volume for Exact Sciences on INDmoney from India has reduced in the last 30 days as on Dec 27, 2024. -8% less investors are searching Exact Sciences in the last 30 days versus the previous period.

Global Institutional Holdings in Exact Sciences

FMR Inc
11.70%
Vanguard Group Inc
9.60%
Capital World Investors
8.56%
Wellington Management Company LLP
7.74%
BlackRock Inc
6.52%
State Street Corp
3.61%

Analyst Recommendation on Exact Sciences

Buy

89%Buy

10%Hold

0%Sell

Based on 29 Wall street analysts offering stock ratings for Exact Sciences(by analysts ranked 0 to 5 stars)

Based on 29 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Exact Sciences

What analysts predicted

Upside of 25.01%

Current:

$57.48

Target:

$71.86

Insights on Exact Sciences

Price Movement
In the last 7 days, EXAS stock has moved down by -3.2%
Increasing Revenue
Revenue is up for the last 3 quarters, 637.52M → 708.65M (in $), with an average increase of 5.1% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, -15.80M → -38.23M (in $), with an average decrease of 141.9% per quarter
EXAS vs DHR (1 yr)
In the last 1 year, Exact Sciences Corporation has experienced a drawdown of -24.0%, however Danaher Corp. resisted the overall trend and outperformed by 23.3%
Price to Sales
ForEXAS every $1 of sales, investors are willing to pay $3.9, whereas for Danaher Corp., the investors are paying $7.2 for every $1 of sales.

Exact Sciences Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$454.5M	↑ 70.86%
Net Income	$-175.1M	↑ 53.11%
Net Profit Margin	-38.54%	↑ 4.47%

	FY19	Y/Y Change
Revenue	$876.3M	↑ 92.82%
Net Income	$-84.0M	↓ 52.04%
Net Profit Margin	-9.59%	↑ 28.95%

	FY20	Y/Y Change
Revenue	$1.5B	↑ 70.19%
Net Income	$-848.5M	↑ 910.24%
Net Profit Margin	-56.9%	↓ 47.31%

	FY21	Y/Y Change
Revenue	$1.8B	↑ 18.49%
Net Income	$-595.6M	↓ 29.81%
Net Profit Margin	-33.71%	↑ 23.19%

	FY22	Y/Y Change
Revenue	$2.1B	↑ 17.95%
Net Income	$-623.5M	↑ 4.68%
Net Profit Margin	-29.91%	↑ 3.8%

	FY23	Y/Y Change
Revenue	$2.5B	↑ 19.93%
Net Income	$-204.1M	↓ 67.26%
Net Profit Margin	-8.17%	↑ 21.74%

	Q2 FY23	Q/Q Change
Revenue	$622.1M	↑ 3.26%
Net Income	$-81.0M	↑ 9.27%
Net Profit Margin	-13.02%	↓ 0.71%

	Q3 FY23	Q/Q Change
Revenue	$628.3M	↑ 1.0%
Net Income	$794.0K	↓ 100.98%
Net Profit Margin	0.13%	↑ 13.15%

	Q4 FY23	Q/Q Change
Revenue	$646.9M	↑ 2.95%
Net Income	$-49.8M	↓ 6367.76%
Net Profit Margin	-7.69%	↓ 7.82%

	Q1 FY24	Q/Q Change
Revenue	$637.5M	↓ 1.45%
Net Income	$-110.2M	↑ 121.49%
Net Profit Margin	-17.29%	↓ 9.6%

	Q2 FY24	Q/Q Change
Revenue	$699.3M	↑ 9.68%
Net Income	$-15.8M	↓ 85.66%
Net Profit Margin	-2.26%	↑ 15.03%

	Q3 FY24	Q/Q Change
Revenue	$708.7M	↑ 1.34%
Net Income	$-38.2M	↑ 141.88%
Net Profit Margin	-5.4%	↓ 3.14%

	FY18	Y/Y Change
Profit	$336.5M	↑ 80.14%

	FY19	Y/Y Change
Profit	$659.6M	↑ 96.02%

	FY20	Y/Y Change
Profit	$1.1B	↑ 72.39%

	FY21	Y/Y Change
Profit	$1.3B	↑ 15.06%

	FY22	Y/Y Change
Profit	$1.5B	↑ 15.41%

	FY23	Y/Y Change
Profit	$1.8B	↑ 22.23%

	Q2 FY23	Q/Q Change
Profit	$465.1M	↑ 4.38%

	Q3 FY23	Q/Q Change
Profit	$459.8M	↓ 1.14%

	Q4 FY23	Q/Q Change
Profit	$475.1M	↑ 3.32%

	Q1 FY24	Q/Q Change
Profit	$467.4M	↓ 1.61%

	Q2 FY24	Q/Q Change
Profit	$486.1M	↑ 4.0%

	Q3 FY24	Q/Q Change
Profit	$512.6M	↑ 5.44%

	FY18	Y/Y Change
Operating Cash Flow	$-69.3M	↓ 3.34%
Investing Cash Flow	$-781.9M	↑ 386.25%
Financing Cash Flow	$934.1M	↑ 257.97%

	FY19	Y/Y Change
Operating Cash Flow	$-115.0M	↑ 65.9%
Investing Cash Flow	$-121.1M	↓ 84.52%
Financing Cash Flow	$253.2M	↓ 72.9%

	FY20	Y/Y Change
Operating Cash Flow	$136.5M	↓ 218.67%
Investing Cash Flow	$-702.0M	↑ 479.85%
Financing Cash Flow	$1.9B	↑ 642.4%

	FY21	Y/Y Change
Operating Cash Flow	$-102.2M	↓ 174.91%
Investing Cash Flow	$-1.1B	↑ 54.14%
Financing Cash Flow	$8.5M	↓ 99.55%

	FY22	Y/Y Change
Operating Cash Flow	$-223.6M	↑ 118.67%
Investing Cash Flow	$74.1M	↓ 106.84%
Financing Cash Flow	$76.5M	↑ 802.8%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$100.4M	↓ 362.79%
Investing Cash Flow	$66.5M	↓ 19.85%
Financing Cash Flow	$16.0M	↓ 87.99%

Exact Sciences Technicals Summary

Sell

Neutral

Buy

Exact Sciences is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Exact Sciences Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Exact Sciences Corporation	-6.82%	36.05%	-24.09%	-21.75%	-37.43%
Idexx Laboratories, Inc.	-1.1%	-14.39%	-25.12%	-35.96%	59.45%
Agilent Technologies Inc.	-1.67%	4.78%	-2.82%	-14.67%	59.99%
Thermo Fisher Scientific, Inc.	1.06%	-4.67%	-1.08%	-19.56%	62.19%
Danaher Corp.	-3.16%	-7.43%	-0.79%	-28.49%	51.32%
Iqvia Holdings Inc.	-0.59%	-5.29%	-13.96%	-28.64%	30.5%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Exact Sciences Corporation	NA	NA	-1.07	-0.56	-0.07	-0.02	NA	17.35
Idexx Laboratories, Inc.	40.0	40.0	4.35	10.73	0.59	0.23	NA	19.72
Agilent Technologies Inc.	30.66	30.66	2.31	5.24	0.25	0.08	0.01	20.53
Thermo Fisher Scientific, Inc.	33.1	33.1	2.02	21.7	0.13	0.05	0.0	128.08
Danaher Corp.	43.46	43.46	3.08	7.5	0.08	0.04	0.0	71.03
Iqvia Holdings Inc.	26.28	26.28	1.06	11.11	0.22	0.05	NA	38.37

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Exact Sciences Corporation	Buy	$10.6B	-37.43%	NA	-7.95%
Idexx Laboratories, Inc.	Buy	$33.9B	59.45%	40.0	22.53%
Agilent Technologies Inc.	Buy	$38.8B	59.99%	30.66	21.75%
Thermo Fisher Scientific, Inc.	Buy	$202.3B	62.19%	33.1	14.48%
Danaher Corp.	Buy	$166.7B	51.32%	43.46	16.39%
Iqvia Holdings Inc.	Buy	$36.3B	30.5%	26.28	9.17%

Exact Sciences Dividend announcements

Exact Sciences Earnings
Exact Sciences’s price-to-earnings ratio stands at None
Read More

About Exact Sciences

exact sciences is a molecular diagnostics company focused on colorectal cancer. the company has exclusive intellectual property protecting its non-invasive, molecular screening technology for the detection of colorectal cancer. stool-based dna (sdna) technology is included in the colorectal cancer screening guidelines of the american cancer society and the u.s. multi-society task force on colorectal cancer. for more information on exact sciences' noninvasive colon cancer screening test, visit cologuardtest.com

Organization	Exact Sciences
Employees	6500
CEO	Mr. Kevin T. Conroy J.D.
Industry	Health Technology

Management People of Exact Sciences

Name	Title
Mr. Kevin T. Conroy J.D.	Chairman of the Board & CEO
Mr. Jake Orville MBA	Executive VP & GM of Screening
Mr. Brian Baranick	Executive VP & General Manager of Precision Oncology
Mr. Aaron Bloomer	Executive Vice President of Finance
Dr. Jorge A. Garces Ph.D.	Chief Science Officer
Mr. Nassar Nizami	Chief Information Officer
Ms. Megan Jones	Associate Manager of Investor Relations
Mr. Tim Caprez	Chief Compliance Counsel & VP
Mr. James Herriott	Senior VP, General Counsel & Secretary
Ms. Sarah Condella	Executive Vice President of Human Resources

Important FAQs about investing in Exact Sciences from India :

What is Exact Sciences share price today?

Exact Sciences share price today stands at $57.48, Open: $57.86 ; Previous Close: $58.11 ; High: $58.55 ; Low: $57.29 ; 52 Week High: $79.62 ; 52 Week Low: $40.62. The stock opens at $57.86, after a previous close of $58.11. The stock reached a daily high of $58.55 and a low of $57.29, with a 52-week high of $79.62 and a 52-week low of $40.62.

Can Indians buy Exact Sciences shares?

Yes, Indians can invest in the Exact Sciences (EXAS) from India.

With INDmoney, you can buy Exact Sciences at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Exact Sciences at zero transaction cost.

How can I buy Exact Sciences shares from India?

It is very easy to buy Exact Sciences from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Exact Sciences be purchased?

Yes, you can buy fractional shares of Exact Sciences with INDmoney app.

What are the documents required to start investing in Exact Sciences stocks?

To start investing in Exact Sciences, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.